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The chemokine receptor CXCR4 
promotes granuloma formation by 
sustaining a mycobacteria-induced 
angiogenesis programme
Vincenzo Torraca, Claudia Tulotta, B. Ewa Snaar-Jagalska & Annemarie H. Meijer
CXC chemokine receptor 4 plays a critical role in chemotaxis and leukocyte differentiation. 
Furthermore, there is increasing evidence that links this receptor to angiogenesis. Using the well-
established zebrafish-Mycobacterium marinum model for tuberculosis, angiogenesis was recently 
found to be important for the development of cellular aggregates called granulomas that contain 
the mycobacteria and are the hallmark of tuberculosis disease. Here, we found that initiation of the 
granuloma-associated proangiogenic programme requires CXCR4 signalling. The nascent granulomas 
in cxcr4b-deficient zebrafish embryos were poorly vascularised, which in turn also delayed bacterial 
growth. Suppressed infection expansion in cxcr4b mutants could not be attributed to an overall 
deficient recruitment of leukocytes or to different intramacrophage bacterial growth rate, as cxcr4b 
mutants displayed similar microbicidal capabilities against initial mycobacterial infection and the 
cellular composition of granulomatous lesions was similar to wildtype siblings. Expression of vegfaa 
was upregulated to a similar extent in cxcr4b mutants and wildtypes, suggesting that the granuloma 
vascularisation phenotype of cxcr4b mutants is independent of vascular endothelial growth factor.
CXCR4 is a critical chemokine receptor that controls migration and differentiation of a variety of cell types1,2. 
In the bone marrow, interaction of CXCR4 with its ligand CXCL12 (SDF1, stromal cell-derived factor 1) is 
required for retention of haematopoietic stem/progenitor cells and their complete differentiation before release 
into circulation3,4. During inflammatory responses, CXCR4 also sustains the trafficking of leukocytes to sites of 
inflammation5. Additionally, CXCR4 signalling on other cells is involved in key migratory mechanisms during 
development and has been linked to the metastatic behaviour of cancer cells6–12. CXCR4 signalling has also been 
connected to tumour-sustained angiogenesis13–15. In particular, CXCR4 stimulation was found to induce expres-
sion of vascular endothelial growth factor (VEGF) in human breast carcinoma cells and conversely blockade of 
CXCL12/CXCR4 signalling was able to suppress tumour angiogenesis and tumour growth in vivo in a murine 
model13. Finally, CXCR4 is also well known to play a critical function in HIV pathogenesis, since this factor rep-
resents an important HIV co-receptor, mediating viral entry into the host cells16.
The existence of a viable cxcr4b knockout has made the zebrafish model particularly attractive to characterise 
the function of CXCR4 signalling in vivo. Originally referred to as Odysseus or Ody, zebrafish cxcr4b mutants 
(cxcr4b−/−) were identified in a forward genetic screen, for factors involved in the migration of primordial germ 
cells17. The mutation harboured by cxcr4b−/− consists in the conversion of the codon AAG in position 709–711 
(coding the amino acid Lys239) into a stop codon, which determines the premature interruption of protein trans-
lation. The resulting truncated protein product lacks the third intracellular loop, the last two transmembrane 
domains, and the C-terminal domain, which compromises the 7-loop transmembrane architecture and therefore 
the capability of CXCR4 to couple with its ligand and its downstream partners (i.e. CXCL12 and heterotrimeric 
G-proteins)17. Similar to mammalian species, the zebrafish Cxcr4b/Cxcl12a signalling axis is also implicated in 
the retention and colonisation of haematopoietic tissues by haematopoietic stem cells, the recruitment of leu-
kocytes to infectious foci and sites of injury, the invasiveness of cancer cells in tumour metastasis, and heart 
regeneration4,12,18–20.
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Tuberculosis (TB) is caused by Mycobacterium tuberculosis (Mtb) infection and this disease typically mani-
fests by the formation of aggregates of infected and non-infected immune cells that are known as granulomas. 
Several studies reported that human tuberculous granulomas, which frequently develop a hypoxic necrotising 
core, are extensively vascularised21–23. However, very little is understood about the actual relevance of angio-
genesis for granuloma formation in TB patients. Additionally, the mechanism by which the vascularisation pro-
gramme is initiated by the pathogen remains elusive24,25. In zebrafish larvae, Mycobacterium marinum (Mm), 
a close relative of Mtb, causes a disease that recapitulates significant aspects of human TB, which include the 
formation of necrotising granulomas and the initiation of specific transcriptional and morphological changes 
in Mycobacterium-infected macrophages26–28. Using the zebrafish model, it was recently found that Mm can also 
induce granuloma-associated angiogenesis and that initiation of this programme coincides with local induction 
of hypoxia and expression of the proangiogenic factor vegfaa25. Notably, the presence of macrophages was strictly 
necessary for mycobacterial-induced vegfaa expression and initiation of granuloma vascularisation. In tumours, 
activation of CXCR4/CXCL12 signalling is tightly linked to both the development of hypoxia and to the activa-
tion of angiogenesis13–15. Therefore, we hypothesised that this chemokine signalling axis could also be involved in 
granuloma-induced angiogenesis.
Here we show that Cxcr4b-deficient zebrafish larvae display an attenuated induction of the angiogenic pro-
gramme at the nascent granulomas. Cellular composition of granulomas and chemotaxis of immune cells to 
infected areas were not altered in cxcr4b mutants compared to wt siblings. Additionally, vegfaa was still expressed 
in cxcr4b deficient larvae, despite the lack of granuloma vascularisation. Taken together, our study indicates that 
Cxcr4b-mediated signalling is required to mediate the full angiogenesis response to mycobacterial infections, and 
that suppression of pathological angiogenesis with CXCR4 blockers might represent an alternative therapeutic 
strategy to suppress granuloma-angiogenesis without perturbing VEGF signalling.
Results
Cxcr4b signalling controls granuloma-induced angiogenesis. To study granuloma-associated angi-
ogenesis, a trunk infection model was recently established in zebrafish embryos (Fig. 1A,B). In this model a 
transgenic Tg(kdrl:eGFP) background (labelling arterial and venous endothelium) was used to monitor host vas-
cularisation in the environment of the nascent granulomatous lesions (Fig. 1C–E)25,29. To study whether cxcr4b 
has a function in granuloma vascularisation, we injected mCherry-fluorescent Mm in cxcr4b mutant and wildtype 
(wt) siblings at 2 days post fertilisation (dpf) and measured bacterial expansion and angiogenesis of the infected 
area at 5 days post infection (dpi) (Fig. 1F–K).
Figure 1. Trunk granuloma formation and induction of angiogenesis by M. marinum. (A,B) Schematic 
representation of injection location and of granuloma expansion in zebrafish embryos/larvae upon injection 
of Mm into the trunk. (C–E) Longitudinal imaging of vascular and bacterial growth during development of 
a trunk granuloma in the Tg(kdrl:eGFP) line at 3, 4 and 5 dpi. (F–K) Formation of trunk granulomas and 
their vascularisation in a cxcr4b+/+ and cxcr4b−/− larva at 5 dpi. White arrows indicate sites of abnormal 
vascularisation associated to bacterial growth, notably largely initiated in the wt but rare in the mutant. See also 
Fig. 2 for quantification. Scale bars: 100 μ m.
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In cxcr4b−/− larvae, the expansion of the infection progressed at a lower rate as compared to the lesions in wt 
(Fig. 1F–K). Simultaneously, the association of angiogenesis with the granulomas was impaired in these mutants 
and, differently from wt, cxcr4b mutants did not have a significant positive correlation between granuloma size 
and length of associated abnormal vasculature (Fig. 2A–C). Indeed, large granulomas failed to induce angiogen-
esis in cxcr4b−/− (Fig. 2D–I). The interdependence between granuloma expansion and angiogenesis had been 
previously described25 and mechanistically closely resembles the angiogenic switch in tumorigenesis, in which 
tumour size is directly related to the local induction of pathogenic angiogenesis30. Altogether, our findings suggest 
that cxcr4b mutation affects granuloma expansion by primarily affecting the initiation of the angiogenesis pro-
gramme, and the difference in infection burden appears to be the consequence, rather than the cause, of impaired 
angiogenic support of granuloma formation. Notably, pharmacological inhibition of Cxcr4b signalling by applica-
tion of two CXCR4 antagonists, namely AMD3100 and IT1t, recapitulated the angiogenesis phenotype of cxcr4b 
genetic knockouts with significant reduction of abnormal vasculature associated to granulomas. The strongest 
effect was observed in case of IT1t application, which also reduced granuloma size, highlighting the therapeutic 
potential of CXCR4 blockers to counteract mycobacterial diseases (Fig. 2J,K).
cxcr4b mutation does not alter the migratory and microbicidal capabilities of macrophages or 
the cellular composition of the granulomatous lesions. Intramacrophage residence of mycobacteria 
is indispensable for initiation of angiogenesis25. Therefore, we investigated whether the difference in promotion 
of angiogenesis in cxcr4b mutants could be explained by aberrant macrophage recruitment (resulting in different 
intracellular/extracellular ratios of Mm), differential microbicidal capability of macrophages, or alteration in the 
macrophage composition of granulomatous lesions. When mycobacteria were injected locally into the hindbrain 
ventricle, a comparable number of leukocytes were promptly recruited (3 hpi) to the infected site in mutants and 
wt (Fig. 3A,B). To assess the possibility of an altered microbicidal capability, we injected the Mm mutant strain 
Δerp, which is highly susceptible to macrophage clearance and replicates intracellularly at a low rate, thereby 
permitting quantification of mycobacterial growth in individual macrophages by live microscopy. At 44 hpi 
the percentage of macrophages displaying low (1–5 bacteria), moderate (6–10 bacteria) or high (> 10 bacteria) 
infection load was quantified and cxcr4b mutants showed similar distribution of the infection phenotypes as wt 
siblings, indicating that depletion of cxcr4b does not alter the macrophage capability to counteract intracellular 
infection (Fig. 3C,D). We also excluded that cxcr4b mutation might affect the content of macrophages in the 
mature granulomas, as the percentage of mycobacteria co-localising with macrophages was similar in mutant 
and wt siblings (Fig. 3E–G). In zebrafish larvae, cxcr4b is expressed both by the macrophage lineage (marked by 
mpeg1) and by the neutrophil lineage (marked by mpx) (Fig. 3H). However, it is unlikely that the angiogenesis 
deficiency in cxcr4b mutants depended on cxcr4b expression by neutrophils, as suggested by irf8 morpholino 
knockdown, which skews myelopoiesis towards neutropoiesis at the expense of primitive macrophage devel-
opment (Fig. 3I,J)31. In this situation the initial deficiency in macrophages was already sufficient to abrogate the 
angiogenic response, indicating that neutrophils alone cannot support angiogenesis and therefore that the cxcr4b 
mutation phenotype implicates a macrophage-related function. However, since recruitment of macrophages, cel-
lular composition of lesions and intramacrophage killing of bacteria were comparable between mutants and wt 
(Fig. 3), we hypothesised that cxcr4b mainly affects the interaction of the macrophages with the surrounding 
tissue.
Mutation of cxcr4b does not interfere with induction of Vegf signalling and with physiological 
angiogenesis. Since CXCR4 was previously linked to tumour angiogenesis via a transcriptional control on 
VEGF signalling13, we addressed whether cxcr4b mutation controlled granuloma angiogenesis by affecting Vegf 
signalling. Treatment with Sunitinib (a Vegf receptor inhibitor)32 or cxcr4b mutation reduced trunk granuloma 
size to the same level (Fig. 4A), although Vegf receptor inhibition could still synergise with cxcr4b mutation 
and could suppress more severely granuloma vascularisation (Fig. 4B). However, it should be noted that treat-
ment with Sunitinib also affected to some extent physiological angiogenesis, as the frequency of physiological 
sprouting from intersegmental vessels (ISVs) and their fusion to the following ISV was also reduced by this 
treatment (Fig. 4C–E). In contrast, cxcr4b mutation affected specifically the granuloma-induced angiogenesis 
and not the physiological sprouting of axial vessels from ISVs. Since the angiogenesis response to mycobacterial 
infection was found to coincide with local induction of vegfaa25 and mammalian CXCR4 has been linked to a 
transcriptional regulation of VEGFA13, we addressed whether cxcr4b affected granuloma-induced angiogenesis 
by exerting a similar transcriptional control on vegfaa expression in our model. Whole mount qRT-PCR analysis 
revealed that both mutants and wt upregulated vegfaa to a comparable level (Fig. 4F). We also found that the 
levels of vegfaa induction, although significant, were limited (1.5-fold) when compared to the induction of other 
infection-inducible genes, which could be seen highly upregulated in the same conditions (Fig. 4F). Likewise, 
expression of cxcl12a (encoding the ligand of Cxcr4b) showed limited but comparable induction in mutants and 
wt (Fig. 4F). Expression of cxcr4b mRNA was not relevantly altered by the infection and remained comparable 
between wt and mutants (as mentioned above, the cxcr4b mutant mRNA differs from the wt only because of a 
non-sense point mutation and can, therefore, be normally tested by qRT-PCR). These results suggest that the 
reduced angiogenic response to granulomas in cxcr4b mutants is not dependent on Vegf signalling, and that 
Cxcr4b axis might therefore act downstream of this pathway.
Cxcr4b mutation is associated with reduced inflammatory gene expression but il1b signalling 
is dispensable for granuloma angiogenesis. Signalling via CXCR4 has been linked to the induction of 
inflammatory genes during the response to infections33,34 and the local chronic induction of inflammation media-
tors is known to play a critical role to sustain angiogenesis of damaged/inflamed tissues35,36. Several inflammatory 
molecules (such as IL1β and TNFα ) have been largely connected to the sustenance of pathological angiogenesis 
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Figure 2. Cxcr4b mutation impairs granuloma-induced angiogenesis. (A,B) cxcr4b mutants display a 
reduced expansion rate of local granulomatous lesions (A), which coincided with the incapability to induce an 
angiogenic programme (B). (C) Vascularisation/granuloma expansion correlation analysis. In wt, the expansion 
of the granulomas depends on the activation of the angiogenic programme at the infection focus. Differently, 
in cxcr4b mutants, no significant correlation between granuloma size and vessel length could be observed 
and even large granulomas failed to initiate angiogenesis, suggesting that the differential activation of the 
angiogenic programme is not the effect, rather the cause, of reduced burden in mutants. Aberrant vasculature 
was measured as the two-dimensional length of vessels not found in uninfected larvae and that solely form 
in association to granulomas. Infection cluster size was measured as the two-dimensional area of individual 
trunk lesions. Values are expressed in percentage relative to average infected cxcr4b+/+ (set to 100%). Statistics 
in C indicates that the slopes of cxcr4b−/− and cxcr4b+/+ trend lines are significantly different (linear regression 
comparison test) and that in wt (but not in mutants) this slope is different from 0 (x axis, Pearson correlation 
test). Each data point in A-C refers to individual trunk granulomas at 5 dpi. Experiments were performed 
in 3 replicates (cumulated in the graphs), each with 4–12 larvae per group. Total number of granulomas 
analysed: 40 (cxcr4b+/+), 52 (cxcr4b−/−). (D–I) Representative images of comparably-sized 5 dpi trunk 
granulomas in cxcr4b−/− and cxcr4b+/+ (quantified in A–C). Notably cxcr4b−/− granulomas display a defect in 
local vascularisation, which is independent of the granuloma size. Scale bars: 100 μ m. (J–K) Treatments with 
CXCR4 antagonists AMD3100 and IT1t phenocopy cxcr4b mutants and display attenuated (IT1t) expansion of 
granulomatous lesions (J) and reduced (AMD3100 and IT1t) induction of granuloma-associated angiogenesis 
(K). Experiments in J–K were performed in Tg(fli1a:eGFP) background. Data are analysed as in Fig. 2A,B. 
Experiments were performed in 2 replicates (cumulated in the graphs). Total number of granulomas analysed: 
101 (vehicle), 101 (AMD3100), 103 (IT1t).
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Figure 3. cxcr4b is not required for the establishment of macrophage parasitism, but macrophages are 
necessary to mediate cxcr4b-dependent angiogenesis. (A,B) Recruitment of macrophages (A) and neutrophils 
(B) 3 hours post local hindbrain (HB) infection at 2 dpf with Mm was unaffected by cxcr4b mutation. Each 
data point in (A,B) represents the recruitment measured in 1 embryo. Experiments were performed in 2 
replicates (cumulated in the graphs), each with 17–35 embryos per group. Total number of embryos analysed: 
38 (Mock-cxcr4b+/+), 41 (Mock-cxcr4b−/−), 53 (Mm-cxcr4b+/+), 49 (Mm-cxcr4b−/−). C–D cxcr4b is dispensable 
for the capability of macrophages to counteract intracellular replication of Mm Δerp. Infected macrophages 
(mpeg1:mCherry-F+) were classified into three phenotypic classes, according to the severity of intracellular 
infection (1–5, 6–10, or > 10 bacteria). (C) represents the percentage of macrophages per larva that populates 
each class. (D) represents the overall distribution of macrophage phenotypes (macrophages from all larvae 
cumulated). Experiments were performed in 2 replicates (cumulated in the graphs), each with 16–17 larvae 
www.nature.com/scientificreports/
6Scientific RepoRts | 7:45061 | DOI: 10.1038/srep45061
in inflammatory diseases35,37. In agreement, the use of the transgenic reporter Tg(il1b:eGFP-F)38 revealed high 
expression of il1b by Mm-infected cells composing the granulomatous lesions in zebrafish larvae (Supplementary 
Figure S1). Therefore, we analysed the expression profile of il1b and several other Mm-inducible inflammatory 
genes (tnfa, cxcl11aa, cxcl18b and mmp9)39–41. All these genes could be still induced in cxcr4b mutants. However, 
two of the analysed genes, namely cxcl18b and il1b were significantly less induced in the mutants, when compared 
to wt (Fig. 4F). This suggests that a differential inflammatory response can be elicited in cxcr4b mutants and 
wt during the infection progression. To address whether the differential induction of il1b might play a role in 
mediating the cxcr4b phenotype, we depleted il1b by morpholino knockdown. Morphants displayed comparable 
vascularisation of trunk granulomas as controls, therefore excluding that the cxcr4b mutant phenotype could be 
caused by reduced il1b signalling (Supplementary Figure S1).
In conclusion, our data show that Cxcr4b is required for granuloma vascularisation by a mechanism that 
appears to be independent from Vegf or the primary proinflammatory cytokine Il1β . Loss of Cxcr4b function 
limits granuloma expansion to a similar degree as Vegfr blockade, suggesting CXCR4 inhibition as an alternative 
host-directed therapeutic approach for TB treatment without side effects on physiological angiogenesis.
Discussion
Using intravital imaging in the zebrafish–Mm infection model, we have investigated the function of the homoe-
ostatic chemokine receptor Cxcr4b in the development of mycobacterial infection and granuloma formation. 
We found that zebrafish embryos/larvae carrying a homozygote mutation of cxcr4b, developed an attenuated 
disease which could be associated with the inability of these mutants to induce local angiogenesis. This granuloma 
angiogenesis defect could be recapitulated with pharmacological inhibitors of CXCR4 (AMD3100 and IT1t). 
Supporting that Cxcr4b promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis pro-
gramme, the positive correlation between granuloma growth and angiogenesis that is normally observed in wt 
larvae, was lost in cxcr4b mutants. Furthermore, pharmacological blockade of the angiogenesis programme by 
Vegfr inhibitor could fully abolish the differences between mutants and wt in the exacerbation of mycobacterial 
infection. The use of angiogenesis inhibitors has previously been proposed as a host-targeted therapy to suppress 
the formation of granulomas in TB patients25. Based on our results, the CXCR4 receptor could be explored as a 
novel target for anti-angiogenic tuberculosis therapy.
It is unlikely that the granuloma angiogenesis phenotype requires expression of cxcr4b by the endothelial cells 
per se, since several studies have identified that venous/arterial endothelium (kdrl+) does not express high levels 
of cxcr4b and that this gene can be found expressed only in developing lymphatic vessels (kdrl−)18,42. Our study 
suggests that cxcr4b function in evoking angiogenesis requires the presence of macrophages, since skewing hae-
matopoiesis towards neutrophils at the expenses of macrophages severely affected the induction of the granuloma 
vascularisation. This conclusion is in line with previous data showing that macrophage depletion by transcription 
factor spi1/pu.1 knockdown reduced the formation of new vessels to the Mm infection foci25. Together, these 
results support that cxcr4b exerts its function on macrophages in a cell-autonomous fashion and affects their 
capability to promote angiogenesis.
Macrophages of cxcr4b mutants were normally capable of migrating to initial mycobacterial infection foci 
and were equally suited to contain initial intramacrophage bacterial replication, therefore excluding significant 
effects of cxcr4b on the establishment of mycobacteria/macrophage parasitism. Apart from the deficiency in the 
expansion rate and the absence of associated angiogenesis, infectious lesions of cxcr4b−/− were structurally undis-
tinguishable from those of wt when granulomas of similar sizes were compared. Since previous studies reported 
that the vegfaa expression pattern coincided with the local promotion of granuloma angiogenesis25, we hypothe-
sised that Cxcr4b might support angiogenesis via promotion of vegfaa expression. The induction levels of vegfaa 
in Mm infected larvae were low and we could not detect a significant difference between infected cxcr4b mutants 
and wt. Several studies have shown that VEGF induction in inflammatory processes can be transient and largely 
variable43–45. Therefore, a direct function of cxcr4b in the regulation of Vegf/Vegfr signalling cannot be com-
pletely excluded by our study. Interestingly, we observed a pronounced effect of Vegfr-inhibition, but not cxcr4b 
mutation, on the formation of physiological vessel sprouts from the intersegmental vessels, indicating that while 
per group. Total number of larvae analysed in C: 32 (cxcr4b+/+), 33 (cxcr4b−/−). Total number of macrophages 
analysed in D: 387 (cxcr4b+/+), 334 (cxcr4b−/−). (E–G) % of mpeg1:mCherry-F signal overlapping with Mm-GFP 
signal in cxcr4b−/− and cxcr4b+/+. No significant deviation in macrophage composition of the trunk granuloma 
lesions was detected. Each data point represents 1 granuloma. Experiment was performed in 1 replicate. Total 
number of granuloma analysed: 37 (cxcr4b+/+), 23 (cxcr4b−/−). Representative example images are shown in  
(F and G). (H) Expression of cxcr4b in macrophages (mpeg1+) and neutrophils (mpx+). Both cell subsets express 
cxcr4b at significantly higher levels than the negative (non-fluorescent) cell population. Data represent fold 
changes relative to the negative cell fraction. Cells were sorted at 2 dpf, from at least 100 embryos. Experiment 
was performed in 3 replicates. I-J. Macrophages are indispensable to mediate granuloma vascularisation  
(I) and an increased number of neutrophils (by irf8 morpholino knockdown) cannot compensate for 
macrophage deficiency, neither in cxcr4b−/− nor in cxcr4b+/+. Deficient bacterial expansion in irf8 knockdown 
condition (irf8-MO) compared to standard control morpholino treatment (Stctr-MO) can be attributed to the 
lack of vascularisation as suggested by non-significant differences in burden between the knockdowns and 
control cxcr4b−/− (J). Data are analysed as in Fig. 2A,B, but infections were performed at 33 hpf, instead of 2 dpf. 
Experiments were performed in 1 replicate. Total number of granuloma analysed: 47 (Stctr-MO-cxcr4b+/+), 47 
(Stctr-MO-cxcr4b−/−), 61 (irf8-MO-cxcr4b+/+), 73 (irf8-MO-cxcr4b−/−).
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Figure 4. Deficient granuloma vascularisation in cxcr4b mutation does not strictly depend on aberrant 
Vegf signalling or attenuated expression of inflammatory genes. (A,B) cxcr4b deficiency reduced granuloma 
expansion to a similar extent as blockade of Vegf signalling (VEGFR-inh, treatment with Sunitinib) (A), 
although Vegf inhibition can more severely affect angiogenesis. (B). Data are analysed as in Fig. 2A,B. 
Experiments were performed in 2 replicates (cumulated in the graphs). Total number of granulomas analysed: 
73 (vehicle-cxcr4b+/+), 66 (vehicle-cxcr4b−/−), 109 (VEGFR-inhibitor-cxcr4b+/+), 88 (VEGFR-inhibitor-
cxcr4b−/−). C–E Inhibition of Vegf signalling (C), but not depletion of cxcr4b (D), severely affects physiological 
angiogenesis. Quantification in E was performed by counting the number of sprouts from intersegmental 
vessels (ISV) from images encompassing 6–7 somites in the trunk region (as represented in C,D). Experiment 
was performed in 2 replicates (cumulated in the graph). Total number of region of interest analysed: 73 (vehicle-
cxcr4b+/+), 59 (vehicle-cxcr4b−/−), 93 (VEGFR-inhibitor-cxcr4b+/+), 77 (VEGFR-inhibitor-cxcr4b−/−). Scale 
bar: 100 μ m. (F) At 5 dpi, Cxcr4b does not exert a transcriptional control on vegfaa expression, but affects the 
inflammatory response to mycobacterial infection, in particular by dampening il1b expression. qRT-PCR were 
performed whole mount from pools of at least 10 embryos (4 replicates). Data represent fold changes of Mm 
infection groups relative to their mock injection (2% PVP in PBS) control group (set to 1, dotted line). No 
significant differences in basal expression levels were found between mutants and wt for the analysed genes.
www.nature.com/scientificreports/
8Scientific RepoRts | 7:45061 | DOI: 10.1038/srep45061
Vegfr-inhibitors act as wide-spectrum angiogenesis blockers, cxcr4b depletion solely inhibits granuloma-induced 
angiogenesis.
Notably, cxcr4b mutation affected propagation of the inflammatory response, since expression of the mas-
ter inflammatory gene il1b was significantly attenuated in cxcr4b mutants. Several reports showed that CXCR4 
signalling can support inflammation. In particular, elegant studies revealed that CXCR4 can cross-talk with the 
plasma membrane Toll-like receptor TLR4 and act as a potent co-stimulatory mediator33,34. There is also growing 
evidence of a tight link between the angiogenesis process and inflammation, since many inflammatory mole-
cules (prostaglandins, TNFα , interleukins such as Il1β ) are proangiogenic too35–37,46,47. Therefore, we investigated 
whether curtailing inflammation via il1b depletion could phenocopy cxcr4b mutation in granuloma-angiogenesis. 
However, our data indicate that suppression of IL1β per se is not sufficient to abrogate the angiogenic response to 
the granulomas.
The relevance of inflammation in triggering granuloma-associated angiogenesis and the exact pathways by 
which Cxcr4b controls the proangiogenic signalling awaits a more detailed characterisation and the zebrafish 
model may represent an elective surrogate system to further address the angiogenesis/inflammation interplay 
in vivo. An attractive hypothesis is that CXCR4 signalling might control the function that macrophages exert 
in facilitating the engagement of endothelial cells from pre-existing vessels. Recently, macrophages have been 
shown to promote vascular anastomosis, a process by which neighbouring endothelial cells are connected to 
form new vessels, occurring in angiogenesis and de novo vasculogenesis48. Notably, this report also suggests that 
macrophage-mediated anastomosis acts downstream of Vegf-mediated tip cells induction, delineating a two-step 
model compatible with our finding that cxcr4b mutants are unable to complete the angiogenic programme, 
despite the fact that Vegfaa signalling is induced.
Concluding, the angiogenesis programme mounted at the granuloma is important to sustain the further 
expansion of the lesion and is a complex multifaceted process that involves pathogen virulence factors, mac-
rophage response to intracellular infection and granuloma aggregation, induction of local hypoxia and VEGF 
signalling25. Our addition to this scenario is that the homoeostatic chemokine receptor CXCR4 is also critical 
to permit the induction of the angiogenic programme and to contain the propagation of inflammation. While 
inhibition of Vegf signalling or depletion of cxcr4b lead to comparable attenuation of granuloma expansion in 
the zebrafish model, blockade of Vegf signalling significantly affected also physiological vascularisation, while 
the effect of cxcr4b mutation was specific towards the granuloma-associated vasculature. In terms of therapeutic 
applications, this suggests that antagonising CXCR4 signalling might be a preferred system to specifically curtail 
pathological angiogenesis. Additionally, in case of TB infections, blockade of CXCR4 may represent a preferential 
treatment of HIV/Mtb co-infected patients. Given the fact that CXCR4 plays a relevant function in HIV entry, 
suppression of CXCR4 could simultaneously counteract both mycobacterial and viral infection.
Methods
Zebrafish lines and maintenance. Zebrafish lines were handled in compliance with the local animal 
welfare regulations and maintained according to standard protocols (zfin.org). The study was approved by the 
local animal welfare committee (DEC) of the University of Leiden (licence number: 10612, protocol 14227). Fish 
lines used in this work were the following: wildtype strain AB/TL, Tg(il1b:eGFP-Fzf550)38, Tg(fli1a:eGFPy1)49, the 
double transgenic line Tg(mpeg1:mCherry-Fump2/mpx:eGFPi114)50,51, cxcr4b homozygote mutant (cxcr4b−/−) and 
wildtype (cxcr4b+/+) siblings of (cxcr4bt26035)12,17 crossed into the transgenic backgrounds of Tg(kdrl:eGFPs843)29 or 
Tg(mpeg1:mCherry-Fump2). Embryos were grown at 28.5 °C in egg water (60 μ g/ml sea salt, Sera Marin, Heinsberg, 
Germany). Larvae destined to image acquisition were maintained in egg water supplemented with 0.003% PTU 
(1-phenyl-2-thiourea, Sigma-Aldrich, St Louis, MO, USA) from 8–12 hpf to prevent melanisation. Anaesthesia 
of embryos/larvae used for live imaging was achieved with 0.02% buffered Tricaine (3-aminobenzoic acid ethyl 
ester, Sigma-Aldrich) in egg water.
Bacterial cultures and infection delivery. Approximately 60–100 CFU suspended in a volume of 10 nl 
of M. marinum strain M (or where specified its isogenic mutant strain Δerp) constitutively expressing mCherry, 
eGFP or mWasabi52,53 were injected into the trunk at 2 dpf25, while approximately 50 CFU in a volume of 1 nl 
were injected into the hindbrain (HB, 2 dpf). For recruitment assays and qRT-PCR experiments, the same vol-
ume of mock [2% polyvinylpyrrolidone-40 (Sigma-Aldrich) in phosphate buffer saline (PBS)] was injected in 
control embryos, as a reference control. Bacteria were grown and harvested from an O/N culture as described 
previously40,54. For morpholino experiments (irf8 and il1b knockdown) and collection of samples for qRT-PCR, 
trunk infections were performed at 33 hpf (instead of 2 dpf). For the assessment of the microbicidal activity of 
macrophages against initial mycobacterial infection, single cell suspensions of Mm Δerp-mWasabi were injected 
into the caudal vein at 33 hpf from − 80 °C frozen single-use aliquots, using a protocol adapted from reference53. 
Briefly, bacteria from a 1-week-old plate were inoculated to an OD600 of 0.2 in 10 ml 7H9 medium supplemented 
with ADC enrichment. The culture was grown for 24 h to reach an OD of approximately 1.0. Bacteria were washed 
3 times with PBS and suspended in PBS supplemented with 10% glycerol to an OD600 of 5.0. To generate a single 
cell suspension, bacteria were passed 10 times through a syringe. 50 μ l aliquots were frozen in liquid nitrogen and 
stored at − 80 °C. Upon thawing, the vital bacteria were quantified by plating as being approximately 100 CFU/nl. 
For quantification of macrophage and neutrophils recruitment to mycobacteria, 2 dpf embryos were infected in 
the hindbrain, fixed at 3 hpi in 4% paraformaldehyde in PBS supplemented with 0.08% Triton X-100 and prepared 
for combined L-plastin (Lp) immunostaining and myeloperoxidase (Mpx) enzymatic activity staining as in refer-
ence55. Leukocytes accumulated at the injected cavity (macrophages: Lp-positive and Mpx-negative; neutrophils: 
Mpx-positive) were counted using a Leica MZ16FA fluorescence stereomicroscope (Leica Microsystems, Rijswijk, 
The Netherlands).
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RNA isolation, FACS and qRT-PCR. To evaluate the induction of genes upon infections (Fig. 4F), 
whole-embryo RNA extraction, cDNA synthesis and qRT-PCR were performed at 5 dpi from a pool of embryos 
injected at 33 hpi (4 replicates), according to the procedure described in reference40. To demonstrate expres-
sion by phagocytes (Fig. 3H), RNA was isolated from mpx+ and mpeg1+ cells sorted at 2 dpf from the double 
transgenic line Tg(mpeg1:mCherry-Fump2/mpx:eGFPi114), according to previous reports40,56. Reference housekeep-
ing genes were ppia1b for whole-mount samples and eif4a1b for FACS-sorted samples. qRT-PCR primers are 
reported in Supplementary Table S1.
Pharmacological inhibition of VEGF and CXCR4 signalling. For pharmacological inhibition of 
VEGF signalling, the VEGFR tyrosine kinase inhibitor Sunitinib (1 μ M, Sigma-Aldrich) or vehicle treatment 
(0.1% DMSO, Sigma-Aldrich), were applied directly to the egg water (immediately after infection) and refreshed 
every 2 days according to reference32. Similarly, for pharmacological suppression of the CXCR4 axis, we applied 
the CXCR4 antagonists AMD3100 (25 μ M, Sigma-Aldrich)18, IT1t (20 μ M, Calbiochem, Merk, Darmstadt, 
Germany)12 or vehicle treatment (0.1% DMSO) via bath exposure of infected embryos. In this case drugs were 
not refreshed during the whole experimental course.
Irf8 and il1b knockdown. All morpholinos were obtained from Gene tools. 1 nl of 1 mM irf8 splicing 
morpholino (5′ -AATGTTTCGCTTACTTTGAAAATGG-3′ )31, 1 nl of 0.6 mM il1b splicing morpholino (5′ 
-CCCACAAACTGCAAAATATCAGCTT-3′ )57,58, or the same concentration and volumes of a standard control 
morpholino (5′ -CCTCTTACCTCAGTTACAATTTATA-3′ ) were injected in one-cell stage zebrafish fertilised 
eggs according to reference31.
Imaging and image quantification. Fixed or live embryos and larvae were imaged using a Leica MZ16FA 
fluorescence stereomicroscope. The size of individual granulomas was quantified at 5 dpi (at 4 dpi in case of irf8 or 
il1b morpholino knockdown) by pixel count, using Fiji/ImageJ software (NIH, Bethesda, MD, USA). The length 
of abnormal vasculature at the granulomas was quantified at the same stage from images according to refer-
ence25 and using the Tg(kdrl:eGFP) or, where specified, the Tg(fli1a:eGFP) transgenic lines. Briefly, the cumulated 
two-dimensional length of vessels not seen in uninfected larvae (aberrant sprouts from the dorsal longitudinal 
anastomic vessel or from the intersegmental vessels, and axial vessels anomalously redirected to grow towards 
the granulomas) was measured per each granuloma. To score the microbicidal activity of macrophages against 
mycobacteria, MmΔerp-mWasabi bacteria prepared as described above were injected into the caudal vein of 
Tg(mpeg1:mCherry-F)/cxcr4b−/− and Tg(mpeg1:mCherry-F)/cxcr4b+/+ embryos. Intramacrophage mycobacterial 
sites of growth were counted (blind) from fixed embryos at 44 hpi according to reference53, using Zeiss Observer 
6.5.32 confocal microscope and a C-Apochromat 63x/1.20 W Korr UV-VIR-IR M27 objective (Carl Zeiss, 
Sliedrecht, The Netherlands). The level of infection per macrophage was classified into three groups based on 
bacterial content (1–5 bacteria, 6–10 bacteria or > 10 bacteria). To estimate similar macrophage content of granu-
lomas, the percentage of colocalisation of Tg(mpeg1:mCherry-F) and Mm M-eGFP was quantified ad 5 dpi using 
Fiji/ImageJ dedicated colocalisation plugin. Confocal images in Supplementary Figure S1 were taken from trunk 
granulomas at 5 dpi/6 dpf, using Zeiss Observer 6.5.32 confocal microscope and an EC Plan-Neofluar 20x/0.50 
M27 (Supplementary Figure S1A) or C-Apochromat 63x/1.20W Korr UV-VIR-IR M27 objective (Supplementary 
Figure S1B).
Statistical analysis. Statistical significance was analysed using GraphPad Prism 6 or 7 (GraphPad Software, 
La Jolla, CA, USA). Differences in granuloma sizes, angiogenesis, and bacteria/macrophage co-localisation 
(Fig. 2A–B–J–K, Fig. 3E–I–J, Fig. 4A,B, Supplementary Figure S1C,D) were statistically tested by unpaired t-test 
(comparison between 2 groups) or one-way ANOVA followed by Šidák comparison test (multiple group com-
parisons). Difference in number of leukocytes recruited and number of physiological sprouts (Fig. 4A–B–E) were 
analysed by Kruskal-Wallis test for non-parametric data followed by Šidák comparison test. Bacterial cluster size/
angiogenesis correlation (Fig. 2C) was analysed by Pearson correlation test and the difference between mutant and 
wt regressions was computed by GraphPad Prism dedicated linear regression analysis tool. Individual unpaired 
t-tests per each class of macrophage phenotype were used to compare the percentage of MmΔerp-infected mac-
rophages per larva (Fig. 3C), while a chi-square contingency test was used to test the overall distribution of mac-
rophage phenotypes (Fig. 3D).
For qRT-PCR (Fig. 4F), statistical significance was estimated by two-tailed t-tests on ln(n)-transformed 
relative induction folds. Significance (P-value) is indicated with: ns, non-significant; *P < 0.05; **P < 0.01; 
***P < 0.001, ****P < 0.0001. Error bars: mean ± s.e.m.
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